Examkin

Soru

Zorluk: OrtaPreventive Care and Screening

Establishing care for a new primary care physician, a 72-year-old biological male is evaluated in the ambulatory setting to discuss his health maintenance plan. He has a 45 pack-year history of cigarette smoking but successfully achieved cessation 12 years ago. His medical history includes severe chronic obstructive pulmonary disease requiring continuous home oxygen therapy, as well as New York Heart Association class III heart failure with a left ventricular ejection fraction of 25%. Current medications include sacubitril-valsartan, carvedilol, spironolactone, empagliflozin, and multiple inhaled therapies. His most recent colonoscopy at age 65 was unremarkable, and he received the 20-valent pneumococcal conjugate vaccine last year. When discussing preventive cancer screening, the patient inquires about his risk for lung cancer and whether he should undergo imaging. Based on current guidelines, which of the following is the most appropriate recommendation regarding lung cancer screening for this patient?

  1. A
    Order annual low-dose computed tomography, as he meets both the age and smoking history criteria
  2. B
    Order an annual posterior-anterior chest radiograph to provide surveillance while minimizing radiation exposure
  3. Advise against screening, as his comorbid conditions substantially limit his candidacy for curative surgical interventionCevap
  4. D
    Advise against screening, as surveillance is no longer indicated for patients after the age of 70 years
  5. E
    Advise against screening, as patients who have abstained from smoking for more than 10 years no longer require surveillance

Cevap

The correct approach is to advise against lung cancer screening because the patient's severe comorbid conditions (oxygen-dependent COPD and advanced heart failure) substantially limit his life expectancy and candidacy for curative surgical intervention.
The correct answer advises against screening due to the patient's severe comorbidities. While the patient meets the standard numerical parameters for lung cancer screening (age 50-80, ≥\ge 20 pack-year smoking history, and quit within the past 15 years), current United States Preventive Services Task Force (USPSTF) guidelines explicitly state that screening should be discontinued if a patient develops a health problem that substantially limits their life expectancy or their ability to undergo curative lung surgery. This patient's continuous oxygen requirement for severe COPD combined with advanced heart failure with reduced ejection fraction makes the risks of curative surgical intervention (such as a lobectomy) prohibitively high. Therefore, screening would not offer a mortality benefit and could lead to cascading harms from invasive diagnostic procedures.

Adım Adım Çözüm

1
Evaluate the patient's demographic and smoking data against standard screening criteria.
The patient is 72 years old, has a 45 pack-year smoking history, and quit 12 years ago, which superficially meets the standard criteria (age 50-80, ≥\ge 20 pack-years, currently smoke or quit within 15 years).
Establishing baseline numerical eligibility is the first step in assessing the need for lung cancer screening.
2
Assess the patient's clinical status and comorbidities.
The patient has severe, oxygen-dependent chronic obstructive pulmonary disease and NYHA class III heart failure with an ejection fraction of 25%.
Comorbidities heavily influence the risk-benefit ratio of cancer screening, particularly in older adults.
3
Apply United States Preventive Services Task Force (USPSTF) exclusion caveats for lung cancer screening.
USPSTF guidelines state screening should be discontinued if a patient develops a health problem that limits life expectancy or the ability to tolerate curative lung surgery (e.g., lobectomy).
Patients who cannot safely undergo resection will not experience a mortality benefit from screening and may be subjected to harmful invasive diagnostic procedures.

Anahtar Kavram

Lung cancer screening with low-dose computed tomography should not be performed in patients whose severe comorbidities substantially limit life expectancy or the ability to undergo curative thoracic surgery, even if they meet the age and smoking history criteria.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru